October 24, 2021 02:52 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Lakhimpur Kheri violence: Three more arrested, say sources | Amit Shah's Mission Kashmir begins with visit to slain cop’s family | Tamil film Koozhangal India's official entry into Oscars 2022 | India records 16,326 new COVID-19 cases in past 24 hours | Mamata Banerjee calls upon individuals, organisations, political parties to join forces to defeat BJP
USFDA clears manufacturing plants of India's leading drug companies in 10 days

USFDA clears manufacturing plants of India's leading drug companies in 10 days

India Blooms News Service | @indiablooms | 15 Apr 2020, 08:07 am

Washington/Mumbai/IBNS: The US Food and Drug Administration (USFDA) has cleared the manufacturing plants of India's leading drug companies in 10 days, media reports said.

The decision came amid the shortages of supply of drugs across the world.

Lupin, which is the third largest generic drug supplier in the US by prescriptions, along with Dr. Reddy's Laboratories received reports indicating all investigations by the US drug regulator was closed.

Lupin managing director Nilesh Gupta said as quoted by Economic Times, “We are very happy to have received the EIR for our Nagpur facility, our largest and most advanced oral solid dosage facility."

All these came days after India decided to export anti-malaria drug and a "potent" COVID-19 cure, Hydroxychloroquine, to the US following a "retaliation" threat by Washington.

Though India is treating a number of Coronavirus patients with Hydroxychlorquine, the treatment has found no scientific backing as of yet.